Plunkett Research Online: Midatech Pharma

MIDATECH PHARMA (MTP) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Midatech Pharma PLC is a part of the healthcare sector. As a pharmaceutical company, it focuses on commercializing and developing products in oncology and other therapeutic areas. The company has only one operating segment Pipeline Research and Development. The research and development activities in.....

MIDATECH PHARMA

Ticker: MTP
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 44 1235888300
Fax:
Address: 65 Innovation Drive
Abingdon, Oxon OX14 4RQ United Kingdom

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts
Description

Midatech Pharma PLC is a part of the healthcare sector. As a pharmaceutical company, it focuses on commercializing and developing products in oncology and other therapeutic areas. The company has only one operating segment Pipeline Research and Development. The research and development activities in.....See More See More
Financials Compare to Industry Averages Compare Companies

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture

How to access Plunkett Research data.

Plunkett Research offers affordable options for of business and industry statistics, trends analysis, reports and company analysis. This includes our award-winning Industry Almanacs, eBooks and our Plunkett Research Online data subscription service.

What data challenge can we help you solve today?

Take a Tour

Contact

Testimonials

Your presentation was the highlight of the meeting… Your book was an added plus to our attendees. They rated you as the #1 speaker and I have no doubt they will invite you back to speak again in the near future.

Carol Wynne, Exec. Director, National Society of Certified Health Care Business Consultants

Your research, aggregation of data and publications are excellent. They’re 1 of 3 or 4 “go-to’s” for hard data with nuance and relevance.

Matt Jackson, CEO, FINTECH

One more fine example of the fine publications offered by Plunkett Research. This reference book is particularly timely given the considerable interest in biotech and genetics from scientific, investment and entrepreneurial audiences…Will be an excellent source for nearly any kind of library.

American Reference Books Annual